ECOR
Price
$10.14
Change
-$0.17 (-1.65%)
Updated
Oct 2 closing price
Capitalization
99.45M
27 days until earnings call
Intraday BUY SELL Signals
HAE
Price
$104.72
Change
+$0.35 (+0.34%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
4.81B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ECOR vs HAE

ECOR vs HAE Comparison Chart in %
View a ticker or compare two or three
VS
ECOR vs. HAE commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECOR is a Hold and HAE is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ECOR vs HAE: Fundamental Ratings
ECOR
HAE
OUTLOOK RATING
1..100
8580
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
10055
SMR RATING
1..100
10066
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ECOR's Valuation (59) in the Medical Specialties industry is in the same range as HAE (84). This means that ECOR’s stock grew similarly to HAE’s over the last 12 months.

HAE's Profit vs Risk Rating (55) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that HAE’s stock grew somewhat faster than ECOR’s over the last 12 months.

HAE's SMR Rating (66) in the Medical Specialties industry is somewhat better than the same rating for ECOR (100). This means that HAE’s stock grew somewhat faster than ECOR’s over the last 12 months.

HAE's Price Growth Rating (35) in the Medical Specialties industry is in the same range as ECOR (36). This means that HAE’s stock grew similarly to ECOR’s over the last 12 months.

HAE's P/E Growth Rating (4) in the Medical Specialties industry is significantly better than the same rating for ECOR (100). This means that HAE’s stock grew significantly faster than ECOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ECORHAE
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ECOR: $10.31 vs. HAE: $104.37)
Brand notoriety: ECOR and HAE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ECOR: 142% vs. HAE: 63%
Market capitalization -- ECOR: $99.45M vs. HAE: $4.81B
ECOR [@Medical/Nursing Services] is valued at $99.45M. HAE’s [@Medical/Nursing Services] market capitalization is $4.81B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ECOR’s FA Score shows that 0 FA rating(s) are green while HAE’s FA Score has 1 green FA rating(s).

  • ECOR’s FA Score: 0 green, 5 red.
  • HAE’s FA Score: 1 green, 4 red.
According to our system of comparison, HAE is a better buy in the long-term than ECOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ECOR’s TA Score shows that 3 TA indicator(s) are bullish while HAE’s TA Score has 3 bullish TA indicator(s).

  • ECOR’s TA Score: 3 bullish, 5 bearish.
  • HAE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ECOR and HAE are a bad buy in the short-term.

Price Growth

ECOR (@Medical/Nursing Services) experienced а -9.12% price change this week, while HAE (@Medical/Nursing Services) price change was -1.54% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.19%. For the same industry, the average monthly price growth was -6.00%, and the average quarterly price growth was -2.76%.

Reported Earning Dates

ECOR is expected to report earnings on Oct 29, 2026.

HAE is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.19% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ECOR
Daily Signal:
Gain/Loss:
HAE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHMM72.050.55
+0.77%
John Hancock Multifactor Mid Cap ETF (JHMM)
BSJW24.250.01
+0.04%
Invesco BulletShares 2032 High Yield Corporate Bond ETF (BSJW)
IQSZ32.08N/A
N/A
Invesco Global Equity Net Zero ETF
QBQF26.03-0.02
-0.09%
AllianzIM Growth-100 Buffer15 ETF (QBQF)
EMHY38.38-0.36
-0.93%
iShares J.P. Morgan EM High Yield Bond ETF (EMHY)

ECOR and

Correlation & Price change

A.I.dvisor tells us that ECOR and QDEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
-4.67%
QDEL - ECOR
29%
Poorly correlated
-1.52%
SENS - ECOR
28%
Poorly correlated
-2.06%
PFSA - ECOR
28%
Poorly correlated
-5.56%
AXGN - ECOR
26%
Poorly correlated
-4.77%
BWAY - ECOR
26%
Poorly correlated
-4.55%
More

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with SRTS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-0.88%
SRTS - HAE
44%
Loosely correlated
-1.34%
ECOR - HAE
43%
Loosely correlated
-4.67%
PEN - HAE
43%
Loosely correlated
-0.11%
ATR - HAE
41%
Loosely correlated
-0.24%
STE - HAE
41%
Loosely correlated
-0.32%
More